We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMWD
851
DELISTED
American Woodmark
AMWD
| $7.34M | 0.01% |
96,122
+67,077
| +231% | +$3.9M |
|
852
Williams Companies
WMB
$86.1B
| $7.32M | 0.01% |
224,217
-1,036,210
| -82% | -$31.1M |
|
|
SLAMW
853
CALL
DELISTED
Slam Corp. warrant
SLAMW
| $7.3M | 0.01% |
682,440
-14,146
| -2% | -$2.62K |
|
854
Altimmune
ALT
$599M
| $7.27M | 0.01% |
2,059,290
+462,160
| +29% | +$2.07M |
|
855
CALL
Wells Fargo
WFC
$264B
| $7.24M | 0.01% |
169,600
+91,400
| +117% | +$3.68M |
|
856
Healthpeak Properties
DOC
$14.8B
| $7.24M | 0.01% |
360,089
+344,589
| +2,223% | +$7.15M |
|
857
Assurant
AIZ
$14.3B
| $7.21M | 0.01% |
57,313
+47,910
| +510% | +$5.97M |
|
858
XP
XP
$8.39B
| $7.16M | 0.01% |
+305,019
| New | +$5.18M |
|
859
Atmus Filtration Technologies
ATMU
$4.18B
| $7.13M | 0.01% |
+324,633
| New | +$6.8M |
|
|
AGS
860
DELISTED
PlayAGS
AGS
| $7.12M | 0.01% |
1,260,299
+221,340
| +21% | +$1.29M |
|
861
Cardlytics
CDLX
$21.5M
| $7.11M | 0.01% |
112,539
+13,706
| +14% | +$830K |
|
862
W.W. Grainger
GWW
$60.2B
| $7.1M | 0.01% |
+9,009
| New | +$6.2M |
|
863
Wendy's
WEN
$1.46B
| $7.1M | 0.01% |
326,243
-1,484,962
| -82% | -$33.1M |
|
864
Alarm.com
ALRM
$2.85B
| $7.08M | 0.01% |
136,911
+37,151
| +37% | +$1.83M |
|
865
Pan American Silver
PAAS
$21.6B
| $7.05M | 0.01% |
+483,380
| New | +$7.99M |
|
866
Petco
WOOF
$794M
| $7.01M | 0.01% |
787,349
-101,166
| -11% | -$931K |
|
867
Intapp
INTA
$2.91B
| $6.98M | 0.01% |
166,622
+23,358
| +16% | +$1.01M |
|
|
SLCA
868
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $6.97M | 0.01% |
574,624
-180,778
| -24% | -$2.23M |
|
|
JAMF
869
DELISTED
Jamf
JAMF
| $6.95M | 0.01% |
356,051
-200,687
| -36% | -$3.72M |
|
870
PUT
Lockheed Martin
LMT
$136B
| $6.91M | 0.01% |
15,000
+14,000
| +1,400% | +$6.5M |
|
871
CALL
Morgan Stanley
MS
$340B
| $6.9M | 0.01% |
80,800
+61,000
| +308% | +$5.22M |
|
|
NATI
872
DELISTED
National Instruments Corp
NATI
| $6.87M | 0.01% |
119,756
+28,938
| +32% | +$1.66M |
|
|
ITCI
873
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.87M | 0.01% |
+108,448
| New | +$6.76M |
|
874
Wynn Resorts
WYNN
$10.6B
| $6.86M | 0.01% |
64,990
+43,956
| +209% | +$4.71M |
|
|
UNVR
875
DELISTED
Univar Solutions Inc.
UNVR
| $6.85M | 0.01% |
191,100
+103,923
| +119% | +$3.69M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.